HeartBeam has submitted a 510(k) application to the US Food and Drug Administration (FDA) for its 12-lead electrocardiogram ...
HeartBeam (NASDAQ: BEAT) , a medical technology company advancing cardiac care, has submitted a 510 (k) application to the U.S. Food and Drug Administration (“FDA”) for its 12-lead electrocardiogram ( ...
The FDA submission is backed by robust data from the VALID-ECG pivotal study, which enrolled 198 patients across five ...
Understand the significant growth trajectory of the Handheld ECG Devices segment, which is expected to reach US$1.9 Billion ...
Tech columnist Jennifer Jolly explored CES in Las Vegas to check out the latest in tech innovations this year. One of the ...
By taking action with your doctor, they can properly diagnosis health issues, and help develop an action plan for your life.